Chimera Research Group provides completely independent and actionable investment and trading ideas backed by comprehensive fundamental research of listed companies in the biotech and pharmaceutical sectors. Where appropriate, our recommended trade and investment ideas incorporate the use of simple to more complex option strategies. Our coverage universe is continuously updated to include the best opportunities for up-coming catalysts.